ER and PR expression may be a significant event in the progression of endometrioid carcinoma, which develops from endometrial hyperplasia with the risks of unopposed estrogen signaling in the endometriotic epithelium. The gene discussed is ESR1; the disease is endometrioid adenocarcinoma.